If you liked this article you might like

Biotech Movers: Sangamo, Epizyme, Revance
Biotech Movers: AveXis, Clovis, Epizyme
Epizyme's Positive Cancer Drug Results Likely to Catch the Eye of Celgene, J&J
Alexion Pops, Biogen Falls on Executive Shuffle; Epizyme Recovers As Investors Digest Phase 2 Data